Amantadine is a medication with dual uses, serving both as an antiviral agent and as a treatment for Parkinson's disease. In the antiviral context, amantadine is primarily employed to inhibit the replication of influenza A viruses. It works by blocking the M2 ion channel protein, preventing the release of viral RNA into host cells. This antiviral property has made amantadine a part of influenza prevention and treatment strategies. In neurology, amantadine finds application in the treatment of Parkinson's disease. Although the precise mechanism of its action in this context remains incompletely elucidated, it is thought to influence dopamine release and receptor sensitivity in the brain. This modulation is believed to alleviate certain symptoms associated with Parkinson's disease, including tremors and bradykinesia. Side effects of amantadine include nausea, dizziness, and insomnia. In the case of prolonged use, patients may develop resistance to its antiviral effects. However, its role in managing Parkinson's disease has established amantadine as a valuable component of the therapeutic arsenal for neurologists.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States